Monday, 2 March 2026
  
Login

Australia's most trusted
source of pharma news

Monday, 02 March 2026
News

First rival for antipsychotic med

Posted 2 March 2026 AM

Generic Health has become the first company to register a generic of Pharmaco’s antipsychotic medicine Zyprexa IM under two brand names - Olanzapine GM IM and Olanzapine Lupin IM.

Administered via intramuscular injection and registered on the ARTG back in 2001, Zyprexa IM is indicated for the rapid control of agitation and disturbed behaviours in patients with schizophrenia and related psychoses and in patients with acute mania associated with Bipolar 1 Disorder, when oral therapy is not appropriate. The drug is not listed on the PBS.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (10)

Clinical & Medical, R&D (5)

Regulatory, Pharmacovigilance & QA (5)

Devices (1)

Other (17)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.